Increased levels of SNAP-25 and synaptophysin in the dorsolateral prefrontal cortex in bipolar I disorder

被引:70
作者
Scarr, E
Gray, L
Keriakous, D
Robinson, PJ
Dean, B
机构
[1] Mental Hlth Res Inst Victoria, Rebecca L Cooper Res Labs, Parkville, Vic 3052, Australia
[2] Univ Melbourne, Dept Pathol, Parkville, Vic 3052, Australia
[3] Childrens Med Res Inst, Cell Signalling Unit, Wentworthville, NSW, Australia
[4] Univ Melbourne, Dept Psychiat, Parkville, Vic 3052, Australia
[5] Monash Univ, Dept Psychol Med, Clayton, Vic 3168, Australia
关键词
human; mental disorders; postmortem; synaptophysin; synaptosomal-associated protein-25;
D O I
10.1111/j.1399-5618.2006.00300.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: In order to identify whether the mechanisms associated with neurotransmitter release are involved in the pathologies of bipolar disorder and schizophrenia, levels of presynaptic [synaptosomal-associated protein-25 (SNAP-25), syntaxin, synaptophysin, vesicle-associated membrane protein, dynamin I] and structural (neuronal cell adhesion molecule and alpha-synuclein) neuronal markers were measured in Brodmann's area 9 obtained postmortem from eight subjects with bipolar I disorder (BPDI), 20 with schizophrenia and 20 controls. Methods: Determinations of protein levels were carried out using Western blot techniques with specific antibodies. Levels of mRNA were measured using real-time polymerase chain reaction. Results: In BPDI, levels of SNAP-25 (p < 0.01) and synaptophysin (p < 0.05) increased. There were no changes in schizophrenia or any other changes in BPDI. Levels of mRNA for SNAP-25 were decreased in BPDI (p < 0.05). Conclusion: Changes in SNAP-25 and synaptophysin in BPDI suggest that changes in specific neuronal functions could be linked to the pathology of the disorder.
引用
收藏
页码:133 / 143
页数:11
相关论文
共 60 条
[1]  
ALDER J, 1995, J NEUROSCI, V15, P511
[2]  
Becher A, 1999, J NEUROSCI, V19, P1922
[3]   Gene expression differences in bipolar disorder revealed by cDNA array analysis of post-mortem frontal cortex [J].
Bezchlibnyk, YB ;
Wang, JF ;
McQueen, GM ;
Young, LT .
JOURNAL OF NEUROCHEMISTRY, 2001, 79 (04) :826-834
[4]   SIGNIFICANT REDUCTIONS IN SYNAPSIN BUT NOT SYNAPTOPHYSIN SPECIFIC ACTIVITY IN THE BRAINS OF SOME SCHIZOPHRENICS [J].
BROWNING, MD ;
DUDEK, EM ;
RAPIER, JL ;
LEONARD, S ;
FREEDMAN, R .
BIOLOGICAL PSYCHIATRY, 1993, 34 (08) :529-535
[5]   Lithium ions enhance cysteine string protein gene expression in vivo and in vitro [J].
Cordeiro, ML ;
Umbach, JA ;
Gundersen, CB .
JOURNAL OF NEUROCHEMISTRY, 2000, 74 (06) :2365-2372
[6]   The synaptic-vesicle-specific proteins rab3a and synaptophysin are reduced in thalamus and related cortical brain regions in schizophrenic brains [J].
Davidsson, P ;
Gottfries, J ;
Bogdanovic, N ;
Ekman, R ;
Karlsson, I ;
Gottfries, CG ;
Blennow, K .
SCHIZOPHRENIA RESEARCH, 1999, 40 (01) :23-29
[7]   The neurobiology of bipolar disorder: findings using human postmortem central nervous system tissue [J].
Dean, B .
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2004, 38 (03) :135-140
[8]   A change in the density of [3H]flumazenil, but not [3H]muscimol binding, in Brodmann's Area 9 from subjects with bipolar disorder [J].
Dean, B ;
Pavey, G ;
McLeod, M ;
Opeskin, K ;
Keks, N ;
Copolov, D .
JOURNAL OF AFFECTIVE DISORDERS, 2001, 66 (2-3) :147-158
[9]  
Dean B, 2000, AUST NZ J PSYCHIAT, V34, P560
[10]   Hippocampal synaptic pathology in schizophrenia, bipolar disorder and major depression: a study of complexin mRNAs [J].
Eastwood, SL ;
Harrison, PJ .
MOLECULAR PSYCHIATRY, 2000, 5 (04) :425-432